DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 186 filers reported holding DENALI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,631,864 | -73.0% | 321,467 | -61.4% | 0.04% | -71.8% |
| Q2 2023 | $24,561,084 | +91.0% | 832,297 | +49.1% | 0.15% | +86.2% |
| Q1 2023 | $12,860,168 | +2.5% | 558,167 | +23.8% | 0.08% | -4.8% |
| Q4 2022 | $12,540,920 | +13.7% | 450,950 | +25.4% | 0.08% | +9.1% |
| Q3 2022 | $11,032,000 | +9.7% | 359,473 | +5.2% | 0.08% | +20.3% |
| Q2 2022 | $10,055,000 | +31.6% | 341,674 | +43.9% | 0.06% | +68.4% |
| Q1 2022 | $7,638,000 | -1.7% | 237,423 | +36.3% | 0.04% | +18.8% |
| Q4 2021 | $7,771,000 | -11.7% | 174,242 | -0.2% | 0.03% | -11.1% |
| Q3 2021 | $8,805,000 | -79.1% | 174,528 | -67.5% | 0.04% | -78.9% |
| Q2 2021 | $42,142,000 | +54.3% | 537,246 | +12.3% | 0.17% | +39.0% |
| Q1 2021 | $27,319,000 | -32.2% | 478,442 | -0.6% | 0.12% | -37.9% |
| Q4 2020 | $40,312,000 | -15.7% | 481,284 | -64.0% | 0.20% | -34.9% |
| Q3 2020 | $47,840,000 | +64.4% | 1,335,185 | +11.0% | 0.30% | +44.1% |
| Q2 2020 | $29,098,000 | +45.7% | 1,203,410 | +5.5% | 0.21% | +1.4% |
| Q1 2020 | $19,966,000 | +8.5% | 1,140,257 | +7.9% | 0.21% | +37.7% |
| Q4 2019 | $18,410,000 | +22.9% | 1,056,846 | +8.1% | 0.15% | +5.6% |
| Q3 2019 | $14,978,000 | -27.6% | 977,661 | -1.9% | 0.14% | -28.9% |
| Q2 2019 | $20,680,000 | +8.5% | 996,147 | +21.3% | 0.20% | -3.4% |
| Q1 2019 | $19,061,000 | +1925.6% | 820,904 | +1702.4% | 0.21% | +1500.0% |
| Q4 2018 | $941,000 | -27.0% | 45,546 | -23.2% | 0.01% | -13.3% |
| Q3 2018 | $1,289,000 | +171.4% | 59,269 | +90.4% | 0.02% | +150.0% |
| Q2 2018 | $475,000 | -22.5% | 31,131 | 0.0% | 0.01% | -25.0% |
| Q1 2018 | $613,000 | +25.9% | 31,131 | 0.0% | 0.01% | +33.3% |
| Q4 2017 | $487,000 | – | 31,131 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |